Structural Heart Devices Market Size by Procedure, Type, Region – Segment-Level Market Assessment, Growth Opportunity Analysis, Competitive Mapping & Forecast to 2029
Overview
Structural Heart Devices Market CAGR is expected to be 10.5% during the forecast period and the market size is expected to reach nearly US$ 27.45 Bn. by 2029.
The report includes the analysis of impact of COVID-19 lock-down on the revenue of market leaders, followers, and disrupters. Since lock down was implemented differently in different regions and countries, impact of same is also different by regions and segments. The report has covered the current short term and long term impact on the market, same will help decision makers to prepare the outline for short term and long term strategies for companies by region.
To know about the Research Methodology:-Request Free Sample Report
The structural heart devices market has gained demand in recent years due to the uncompromising rise in mitral regurgitation, aortic stenosis, and other related heart diseases.
A rise in the incidence of aortic stenosis, increase in awareness about the benefits and availability of structural heart devices worldwide, and the introduction of technologically advanced products (such as the Trifecta valve with Glide Technology) has driven the market demand of structural heart devices market. Healthcare expenditure and the growing geriatric population are expected to create market opportunities for the structural heart devices in the future as well. Furthermore, stringent approval process and a high cost of surgeries may hamper the growth of the market acting as some of the major restraints for the market growth.
Structural heart devices market is segmented by product, procedure, and region. Among procedures, surgical aortic valve replacement (SAVR), transcatheter aortic valve replacement (TAVR) segment market accounted for the xx% share in 2021. Surgical aortic valve replacement dominated in 2021 due to its proved efficacy in the treatment and established reimbursement codes.
Based on products, surgical heart valves product is expected to be one of the fastest growing segments in the forecast period. The minimally invasive surgical nature of the procedure is the key reason for this rapid growth.
Among regions, the North America region is expected to grow at the xx5 CAGR during the forecast period due to a high prevalence of cardiovascular disease, increasing adoption of angiographic procedures and rising demand of accurate diagnosis. The Asia Pacific region is expected to grow at the xx% CAGR during the forecast period due to the increasing awareness of cardiac diseases, better newborn screening programs, and improvement in healthcare access.
There is a sturdy growth in the production as new companies are entering the structural heart market. For example, in May 2021, a leading medical devices company, Edwards Lifesciences Corporation (US) announced its intentions to enter the structural heart market.
In the structural heart devices market, Boston Scientific Corporation holds the leading position due to production capacity expansion, brand portfolio expansion, mergers, collaborations, and acquisitions. In 2021, the company has adopted new product launches, product enhancements, and geographic expansion as its crucial business plans to certify its dominance in this market.
The objective of the report is to present comprehensive analysis of Structural Heart Devices market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with analysis of complicated data in simple language. The report covers all the aspects of industry with dedicated study of key players that includes market leaders, followers and new entrants by region.
PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors by region on the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give clear futuristic view of the industry to the decision makers.
The report also helps in understanding Structural Heart Devices market dynamics, structure by analyzing the market segments, and project the Structural Heart Devices market size. Clear representation of competitive analysis of key players by type, price, financial position, product portfolio, growth strategies, and regional presence in the Structural Heart Devices market make the report investor’s guide.
Structural Heart Devices Market Scope: Inquire before buying
• Structural Heart Devices Market, by Product
• Heart Valve Devices
• Surgical Heart Valves
• Transcatheter Heart Valves
• Occluders and Delivery Systems
• Annuloplasty Rings
• Other Devices
• Accessories
• Structural Heart Devices Market, by Procedure
• Replacement Procedures
• TAVR Procedures
• SAVR Procedures
• Repair Procedures
• Closure Procedures
• Annuloplasty
• Valvuloplasty
• TMVR Procedures
Structural Heart Devices Market, by Region
• North America
• Europe
• APAC
• Latin America
• MEA
Structural Heart Devices Market Key Players
• Edwards Lifesciences Corporation
• Medtronic plc
• Abbott
• Boston Scientific Corporation
• LivaNova plc (UK).
• ST.JUDEMEDICAL
• Biomerics,
• Comed BV
• LivaNova PLC
• JenaValve Technology, Inc.
• CardioKinetix
Frequently Asked Questions:
1. Which region has the largest share in Global Structural Heart Devices Market?
Ans: North America region holds the highest share in 2021.
2. What is the growth rate of Global Structural Heart Devices Market?
Ans: The Global Structural Heart Devices Market is growing at a CAGR of 10.5% during forecasting period 2022-2029.
3. What is scope of the Global Structural Heart Devices market report?
Ans: Global Structural Heart Devices Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period.
4. Who are the key players in Global Structural Heart Devices market?
Ans: The important key players in the Global Structural Heart Devices Market are – Edwards Lifesciences Corporation, Medtronic plc, Abbott, Boston Scientific Corporation, LivaNova plc (UK)., ST.JUDEMEDICAL, Biomerics,, Comed BV, LivaNova PLC, JenaValve Technology, Inc., and CardioKinetix
5. What is the study period of this market?
Ans: The Global Structural Heart Devices Market is studied from 2021 to 2029.